| Original language | English |
|---|---|
| Journal | Oncology and Translational Medicine |
| DOIs | |
| Publication status | Accepted/In press - 2026 |
| Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Engineering the future of cancer nanomedicine: From rational design to clinical translation
- Xi Hu
- , Han Lin
- , Li Ma
- , Zhong Guo
- , Mingzhen Zhang
- , Yang Zhu
- , Fangfang Chen
- , Wei Jiang
- , Xudong Shi
- , Jiuyang He
- , Kelong Fan*
- , Xiaoping Chen
*Corresponding author for this work
- Anhui University of Chinese Medicine
- CAS - Shanghai Institute of Ceramics
- Jinan University
- Beijing Normal University
- Xi'an Jiaotong University
- Fujian Medical University
- Jilin University
- Zhengzhou University
- Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College
- Beijing Institute of Technology
- CAS - Institute of Biophysics
- Zhongyuan Nanozyme Laboratory
- Huazhong University of Science and Technology
Research output: Contribution to journal › Article › peer-review